MedicationUse2-v1.0(2017EN) - Bewerkingsoverzicht

Update bot: Copy of

2018-02-20T09:06:06Z

Copy of

Update bot op 30 nov 2017 om 12:42

2017-11-30T12:42:12Z

Update bot op 28 sep 2017 om 09:27

2017-09-28T09:27:33Z

Update bot op 26 sep 2017 om 13:23

2017-09-26T13:23:02Z

Update bot op 21 sep 2017 om 16:01

2017-09-21T16:01:40Z

Update bot: Nieuwe pagina aangemaakt met '==General information== Name: '''nl.zorg.MedicationUse2''' link=MedicatieGebruik2-v1.0(2017NL)
Version: '''1.0'''
HCIM Status:Final
2017-09-21T15:26:39Z

Nieuwe pagina aangemaakt met '==General information== Name: '''nl.zorg.MedicationUse2''' link=MedicatieGebruik2-v1.0(2017NL) Version: '''1.0''' HCIM Status:Final<b...'

Nieuwe pagina
==General information==
Name: '''nl.zorg.MedicationUse2''' [[Bestand:NL.png|link=MedicatieGebruik2-v1.0(2017NL)]] 
Version: '''1.0''' 
HCIM Status:Final 
Publication: '''2017''' 
Release status: Prepublished 
Publication date: 04-09-2017
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>

==Metadata==
{| class="wikitable" style="font-size:90%; width: 750px"
|-
|style="width:250px; "|DCM::CoderList||Projectgroep Medicatieproces
|-
|style="width:250px; "|DCM::ContactInformation.Address||
|-
|style="width:250px; "|DCM::ContactInformation.Name||*
|-
|style="width:250px; "|DCM::ContactInformation.Telecom||
|-
|style="width:250px; "|DCM::ContentAuthorList||Projectgroep Medicatieproces
|-
|style="width:250px; "|DCM::CreationDate||1-2-2017
|-
|style="width:250px; "|DCM::DeprecatedDate||
|-
|style="width:250px; "|DCM::DescriptionLanguage||nl
|-
|style="width:250px; "|DCM::EndorsingAuthority.Address||
|-
|style="width:250px; "|DCM::EndorsingAuthority.Name||PM
|-
|style="width:250px; "|DCM::EndorsingAuthority.Telecom||
|-
|style="width:250px; "|DCM::Id||2.16.840.1.113883.2.4.3.11.60.40.3.9.11
|-
|style="width:250px; "|DCM::KeywordList||Medicatie, Gebruik
|-
|style="width:250px; "|DCM::LifecycleStatus||Final
|-
|style="width:250px; "|DCM::ModelerList||Architectuurgroep Registratie aan de Bron
|-
|style="width:250px; "|DCM::Name||nl.zorg.MedicatieGebruik2
|-
|style="width:250px; "|DCM::PublicationDate||04-09-2017
|-
|style="width:250px; "|DCM::PublicationStatus||Prepublished
|-
|style="width:250px; "|DCM::ReviewerList||Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron
|-
|style="width:250px; "|DCM::RevisionDate||04-09-2017
|-
|style="width:250px; "|DCM::Superseeds||nl.zorg.MedicatieGebruik-v3.0
|-
|style="width:250px; "|DCM::Version||1.0
|-
|style="width:250px; "|HCIM::PublicationLanguage||EN
|}

==Revision History==
<div class="mw-collapsible mw-collapsed">
''Only available in Dutch''

Publicatieversie 1.0 (04-09-2017).
</div>

==Concept==
MedicationUse is a statement on the historic, current or intended use of a certain medicine.

==Purpose==
The goal of the medication use is to provide insight into the patient’s pattern of use.

==Information Model==
 
[[Bestand: MedicationUse2-v1.0Model(EN).png | center]]
 
{| border= "1" width="1500px" style = "font-size: 9.5pt; border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"
|-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; "
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
|-style="vertical-align:top; background-color: #E3E3E3; "
|style = "text-align:center" |[[Bestand: block.png| 20px]]
||NL-CM:9.11.21338
|colspan ="6" style ="padding-left: 0px"|[[Bestand: arrowdown.png | 10px]]MedicationUse
|
|Root concept of the MedicationUse information model. This root concept contains all data elements of the MedicationUse information model.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
||NL-CM:9.11.23290
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px]]Prescriber::HealthProfessional
|0..1
|The health professional that entered the medication agreement with the patient.
|
|
{|
|-
|[[Bestand: block.png]]||[[HealthProfessional-v3.1(2017EN) |HealthProfessional]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
||NL-CM:9.11.21339
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px]]ProductUsed::Product
|1
|The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well.

In principle, this will be the prescribed product, but the product used may differ from the prescribed product.
|
|
{|
|-
|[[Bestand: block.png]]||[[Product-v1.0(2017EN) |Product]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
||NL-CM:9.11.22504
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px]]InstructionsForUse
|0..1
|Instructions for the use of the medication, e.g. dose and route of administration. In the event of medication use, this is the pattern of use established by the patient or which the patient followed.
|
|
{|
|-
|[[Bestand: block.png]]||[[InstructionsForUse-v1.0(2017EN) |InstructionsForUse]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: TS.png| 16px]]
||NL-CM:9.11.22398
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px]]MedicationUseDateTime
|1
|Date on which this use is entered.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
||NL-CM:9.11.22663
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px]]PeriodOfUse
|0..1
|Start date: This is the time at which the agreement was to take effect (or took effect or will take effect).
Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days.
End date: The time at which the period of use ends (or ended or will end). To avoid confusion between 'to' and 'up to', the submission of time is always mandatory for the end date.
|
|
{|
|-
|[[Bestand: block.png]]||[[Zib of versie niet gevonden-v??(2017EN) |Zib of versie niet gevonden]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: BL.png| 16px]]
||NL-CM:9.11.22492
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px]]AsAgreedIndicator
|0..1
|Is the medicine used as outlined in the medication agreement?
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: BL.png| 16px]]
||NL-CM:9.11.22399
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px]]UseIndicator
|1
|Is this medicine used or not?
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px]]
||NL-CM:9.11.22491
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px]]ReasonForUse
|0..1
|The reason for using the medication, particularly in self-care medicine purchased by the patient themselves.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px]]
||NL-CM:9.11.23132
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px]]MedicationUseStopType
|0..1
|Stop type, the manner in which this medication is discontinued (temporary or definitive).
|
|
{|
|-
|[[Bestand: List2.png]]||[[#MedicationUseStopTypeCodeList|MedicationUseStopTypeCodeList]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px]]
||NL-CM:9.11.22493
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px]]ReasonForChangeOrDiscontinuationOfUse
|0..*
|Reason for changing or discontinuing use of medication.
|
|
{|
|-
|[[Bestand: List2.png]]||[[#ReasonForChangeOrDiscontinuationOfUseCodList|ReasonForChangeOrDiscontinuationOfUseCodList]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px]]
||NL-CM:9.11.21624
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px]]Comment
|0..1
|Comments on the medication use.
|
{|
|-
| 48767-8 Annotation comment
|}
|
|}
Columns Concept and DefinitionCode: hover over the values for more information 
For explanation of the symbols, please see the legend page [[Bestand:list2.png|link=Legend]]

==Example Instances==
''Only available in Dutch''

{|class="wikitable" width="1316px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 18%; color: #FFFFFF; font-weight: bold; "|MedicatieGebruik DatumTijd
| style="background-color: #1F497D; width: 4%; color: #FFFFFF; font-weight: bold; "|GebruikIndicator
| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|VolgensAfspraak Indicator
| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|Medicatiegebruik Stoptype
|colspan="3" style="background-color: #1F497D; width: 27%; color: #FFFFFF; font-weight: bold; "|Gebruiksperiode
| style="background-color: #1F497D; width: 28%; color: #FFFFFF; font-weight: bold; "|Gebruiksproduct
|-style=vertical-align:top;
| style="background-color: #548DD4; width: 18%; "|
| style="background-color: #548DD4; width: 4%; "|
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 9%; color: #FFFFFF; font-weight: bold; "|Ingangsdatum
| style="background-color: #548DD4; width: 8%; color: #FFFFFF; font-weight: bold; "|Einddatum
| style="background-color: #548DD4; width: 9%; color: #FFFFFF; font-weight: bold; "|Gebruiksduur
| style="background-color: #548DD4; width: 28%; color: #FFFFFF; font-weight: bold; "|ProductCode
|-style=vertical-align:top;
| style="background-color: #D9D9D9; width: 18%; "|
| style="background-color: #D9D9D9; width: 4%; "|
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 9%; "|
| style="background-color: #D9D9D9; width: 8%; "|
| style="background-color: #D9D9D9; width: 9%; "|
| style="background-color: #D9D9D9; width: 28%; "|
|-style=vertical-align:top;
| style="width: 18%; color: #000000; "|3-6-2014 16:19:07
| style="width: 4%; "|Ja
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 9%; "|Mei 2014
| style="width: 8%; "|
| style="width: 9%; "|1 maand
| style="width: 28%; color: #000000; "|Paracetamol tablet 500 mg
|-style=vertical-align:top;
| style="width: 18%; color: #000000; "|11-9-2012 17:21:00
| style="width: 4%; "|Ja
| style="width: 11%; "|Ja
| style="width: 11%; "|
| style="width: 9%; "|01-09-12
| style="width: 8%; color: #000000; "|05-09-12
| style="width: 9%; "|
| style="width: 28%; color: #000000; "|Pantoprazol injpdr 40 mg fl
|-style=vertical-align:top;
| style="width: 18%; color: #000000; "|19-9-2014 4:12:11
| style="width: 4%; "|Nee
| style="width: 11%; "|Nee
| style="width: 11%; "|Definitief
| style="width: 9%; color: #000000; "|17-09-14
| style="width: 8%; "|
| style="width: 9%; "|
| style="width: 28%; color: #000000; "|Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml
|}
{|class="wikitable" width="1316px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|RedenGebruik
| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|RedenWijzigen OfStoppen Gebruik
|colspan="5" style="background-color: #1F497D; width: 59%; color: #FFFFFF; font-weight: bold; "|GebruiksInstructie
| style="background-color: #1F497D; width: 19%; "|
|-style=vertical-align:top;
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 16%; color: #FFFFFF; font-weight: bold; "|Omschrijving
| style="background-color: #548DD4; width: 9%; color: #FFFFFF; font-weight: bold; "|ToedieningsWeg
| style="background-color: #548DD4; width: 11%; color: #FFFFFF; font-weight: bold; "|Aanvullende instructie
| style="background-color: #548DD4; width: 11%; color: #FFFFFF; font-weight: bold; "|Doseerinstructie
| style="background-color: #548DD4; width: 12%; "|
| style="background-color: #548DD4; width: 19%; "|
|-style=vertical-align:top;
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 16%; "|
| style="background-color: #D9D9D9; width: 9%; "|
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 11%; color: Black; font-weight: bold; "|Doseerduur
| style="background-color: #D9D9D9; width: 12%; color: Black; font-weight: bold; "|Dosering<noWiki>|</noWiki> Keerdosis
| style="background-color: #D9D9D9; width: 19%; color: #000000; font-weight: bold; "|Toedieningsschema <noWiki>|</noWiki>Frequentie <noWiki>|</noWiki>Interval <noWiki>|</noWiki>Toedientijd <noWiki>|</noWiki>Weekdag <noWiki>|</noWiki>Dagdeel 
|-style=vertical-align:top;
| style="width: 11%; "|Pijn
| style="width: 11%; "|
| style="width: 16%; color: #000000; "|In de maand mei heb ik regelmatig paracetamol gebruikt.
| style="width: 9%; "|
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 12%; "|
| style="width: 19%; "|
|-style=vertical-align:top;
| style="width: 11%; "|Ulcusprofylaxe
| style="width: 11%; "|
| style="width: 16%; color: #000000; "|Vanaf 1 september 2012 gedurende 5 dagen 1x per dag om 8uur 40 mg (=1 st)
| style="width: 9%; "|iv
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 12%; color: #000000; "|40 mg (=1 st)
| style="width: 19%; "|1x per dag om 8.00 uur
|-style=vertical-align:top;
| style="width: 11%; "|
| style="width: 11%; color: #000000; "|(Mogelijke) bijwerking
| style="width: 16%; color: #000000; "|Tijdelijk gestopt vanwege toenemende bijwerkingen: duizeligheid en misselijkheid.
| style="width: 9%; "|subcutaan
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 12%; color: #000000; "|2500 IE
| style="width: 19%; color: #000000; "|1x per dag om 18.00 uur 
|}

== Valuesets ==
=== MedicationUseStopTypeCodeList===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.1
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|Tijdelijk
|1
|Medicatieafspraak StopType
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1
|Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie).
|-style="vertical-align:top; "
|Definitief
|2
|Medicatie afspraak StopType
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1
|Het staken van een bestaande medicamenteuze behandeling.
|}

=== ReasonForChangeOrDiscontinuationOfUseCodList===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.2
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|Medication commenced (finding)
|266709005
|SNOMED CT
|2.16.840.1.113883.6.96
|Starten medicamenteuze behandeling
|-style="vertical-align:top; "
|Administration of drug or medicament contraindicated (situation)
|438833006
|SNOMED CT
|2.16.840.1.113883.6.96
|Contra-indicatie
|-style="vertical-align:top; "
|Drug interaction (disorder)
|79899007
|SNOMED CT
|2.16.840.1.113883.6.96
|Interactie
|-style="vertical-align:top; "
|Hypersensitivity condition (disorder)
|473010000
|SNOMED CT
|2.16.840.1.113883.6.96
|Overgevoeligheid
|-style="vertical-align:top; "
|Geen of onvoldoende effect
|5
|Medicatieafspraak Reden
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2
|Geen of onvoldoende effect
|-style="vertical-align:top; "
|Te sterk effect
|6
|Medicatieafspraak Reden
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2
|Te sterk effect
|-style="vertical-align:top; "
|(Mogelijke) bijwerking
|7
|Medicatieafspraak Reden
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2
|(Mogelijke) bijwerking
|-style="vertical-align:top; "
|Toedieningsweg voldoet niet
|8
|Medicatieafspraak Reden
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2
|Toedieningsweg voldoet niet
|-style="vertical-align:top; "
|Indicatie vervallen
|9
|Medicatieafspraak Reden
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2
|Indicatie vervallen
|-style="vertical-align:top; "
|Beleidswijziging
|10
|Medicatieafspraak Reden
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2
|Beleidswijziging
|-style="vertical-align:top; "
|Admission to establishment (procedure)
|305335007
|SNOMED CT
|2.16.840.1.113883.6.96
|Opname
|-style="vertical-align:top; "
|Wens patiënt
|12
|Medicatieafspraak Reden
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2
|Wens patiënt
|-style="vertical-align:top; "
|Volgens afspraak
|13
|Medicatieafspraak Reden
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2
|Volgens afspraak
|-style="vertical-align:top; "
|Hervatten beleid vorige voorschrijver
|14
|Medicatieafspraak Reden
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2
|Hervatten beleid vorige voorschrijver
|-style="vertical-align:top; "
|Geplande procedure
|15
|Medicatieafspraak Reden
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2
|Procedure waaronder ingreep, interferentie met gepland labonderzoek, etc.
|-style="vertical-align:top; "
|Overig
|OTH
|NullFlavour
|2.16.840.1.113883.5.1008
|Overig
|}

==More on this information model==
More technical information and HL7/XML documentation you can find on the Nictiz Art-Decor page about this information model[http://decor.nictiz.nl/art-decor/decor-datasets--zib1bbr-?id=2.16.840.1.113883.2.4.3.11.60.40.3.9.11] 
This information model is also available as [[Media:nl.zorg.MedicationUse2-v1.0(EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationUse2-v1.0(EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
==About this information==
The information in this wikipage is based on Prerelease 2017 #1 
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]] 
This page is generated on 21/09/2017 13:51:20 
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>